Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMEGA: FOLFIRI + Bevacizumab in First-line Metastatic Colorectal Cancer
NCT00467142Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Jan 2007
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Institut Bergonié. Started Jan 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00467142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467142.